AI could outshine standard tumor measurements to predict survival
NCT ID NCT07685548
First seen Jul 06, 2026 · Last updated Jul 09, 2026 · Updated 3 times
Summary
This study is developing an artificial intelligence system that measures changes in total tumor volume from CT or MRI scans to see if it can predict survival better than the current standard method, which measures just a few tumors. Researchers will analyze data from about 6,000 past patients and enroll around 120 new participants with solid tumors who are receiving non-surgical treatment. The goal is to improve how doctors evaluate whether a treatment is working.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this AI approach could provide a more accurate way to predict survival and guide treatment decisions for people with solid tumors.
- What could go wrong
- This is an observational study, not a treatment trial. The AI method may not prove better than current standards, and results may not apply to all tumor types or treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cancer vaccine prime the body to better fight liver tumors?
- Can a targeted pill slow brain tumor growth after surgery?
- Training the immune system to hunt down leftover liver cancer cells
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- Could a genetic marker guide future cancer therapies in taiwan?
- Can a tumor-zapping procedure also wake up the immune system?